Browse > Article

Mechanism of the relaxant action of imipramine in isolated rat aorta  

Kang, Hyung-sub (Bio-Safety Research Institute, Chonbuk National University)
Lee, Sang-woo (Bio-Safety Research Institute, Chonbuk National University)
Baek, Sung-su (Bio-Safety Research Institute, Chonbuk National University)
Joe, Sung-gun (Bio-Safety Research Institute, Chonbuk National University)
Kim, Jin-shang (Bio-Safety Research Institute, Chonbuk National University)
Publication Information
Korean Journal of Veterinary Research / v.43, no.4, 2003 , pp. 597-606 More about this Journal
Abstract
Although the antidepressant effects of imipramine (IMI) have been well known in several studies, the effects on cardiovascular system, particularly the vasorelaxant effects, have not known clearly. We hypothesis that IMI-induced vasorelaxation involves NO (nitrie oxide), activation of guanylate cyclase (GC) and $Ca^{2+}$ channel. The possible roles of the endothelium and $Ca^{2+}$ in IMI-induced responses were investigated using isolated rings of rat thoracic aorta and anesthesized rats. In KCl-precontracted rings. IMI produces endothelium-dependent and endothelium-independent relaxations in intact (+E) as well as endothelium-denuded (-E) rat aorta in a concentration-dependent manner. In phenylephrine (PE)-precontracted rings, the IMI-induced relaxation was significantly greater in +E rings. The IMI-induced relaxations were suppressed by nitric oxide synthase (NOS) inhibitors, N(G)-nitro-L-arginine (L-NNA), N(omega)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine, a non-selective GC inhibitor, methylene blue, $Na^+$ channel blockers, lidocaine and procaine, or $Ca^{2+}$ channel blockers, nifedipine and verapamil, in PE-precontracted +E rings, but not in PE-precontracted -E rings. These relaxations were also suppressed by lidocaine or procaine in -E aortic rings. However, IMI-induced relaxations were not inhibited by a PLC inhibitor 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate (NCDC), an inositol monophosphatase inhibitor, lithium, indomethacin and dexamethasone in +E and -E rings. In vivo, infusion of IMI elicited significant decrease in arterial blood pressure. After intravenous injection of saponin, NOS inhibitors. MB and nifedipine, infusion of IMI inhibited the IMI-lowered blood pressure markedly. These findings suggest that the endothelium-dependent relaxation induced by IMI is mediated by activation of NO/cGMP signaling cascade or inhibition of $Ca^{2+}$ entry through voltage-gated channel, and this mechanism may contribute to the hypotensive effects of IMI in rats.
Keywords
imipramine; endothelium; relaxation; blood pressure; aorta;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Carron, R., Perez-Vizcaino, E, Delpon, E. and Tamareo, J. Effects of propafenone on $^4^5Ca$ movements and contractile responses in vascular smooth muscle. Br. J. Pharmacol. 1991, 103, 1453-457
2 del Pozo, B. F., Perez-Vizcaino, R, Villamor, E., Zaragoza, F. and Tamargo, J. Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta. Br. J. Pharmacol. 1996, 117, 105-110
3 Hishinuma, T., Tsukamoto, H., Suzuki, K. and Mizugaki, M. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot. Essent. Fatty Acids. 2001, 65, 191-196
4 Hudgins, P. M. and Weiss, G. B. DifFerential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephnne, histamine and potassium. J. Pharmacol. Exp. Ther. 1968, 159, 91-97
5 Perez-Vizcaino, F., Duarte, J. and Tamargo, J. Effects of flecainide on isolated vascular smooth muscles of rat. Br. J. Pharmacol. 1991, 104, 726-730
6 Roose, S. R, Glassman, A. H., Giardina, E. G., Walsh, B. T, Woodring, S. and Bigger, J. T. Thcyclic antidepressants in depressed patients with cardiac conduction disease. Arch. Gen. Psychiatry. 1987, 44, 273-275
7 Somlyo, A. P. and Himpens, B. Cell calcium and its regulation in smooth muscle. FASEB J. 1989, 3, 2266-2276
8 Sturek, M. and Hermsmeyer, K. Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science, 1986, 233, 475-478
9 Taggart, M. J., Menice, C. B., Morgan, K. G. and Wray, S. Effect of metabolic inhibition on intracellular$Ca^2^+$, phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J. Physiol. 1997, 499, 485-496
10 Vila, J. M., Medina, P., Segarra, G., Lluch, R, Pallardo, E, Flor, B. and Lluch, S. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br. J. Clin. Pharmacol. 1999, 48, 223-229
11 Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada. K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. Calcium movements, distribution, and functions in smooth muscle Pharmacol. Rev. 1997, 49, 157-230
12 Sheannan, M. S., Sekiguchi, K. and Nishizuka, Y. Modulation of ion channel activity: a key function of the protein kinase C enzyme family. Pharmacol. Rev. 1989, 41, 211-237
13 Villalobos-Molina, R., Uc, M., Hong, E. and Garcia-Sainz, J. A. Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation. J. Pharmacol. Exp. Ther. 1982, 222, 258-261
14 Huang, Y. Inhibition of contractions by tricyclic antidepressants and xylamine in rat vas deferens. Eur. J. Pharmacol. 1997, 327, 41-47
15 Doggrell, S. A. and Vincent, L. The postsynaptic effects of antidepressant drugs in the rat anococcygeus muscle. J. Pharm. Pharmacol. 1981, 33, 720-724
16 Richelson, E. and Nelson, A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J. Pharmacol. Exp. Ther. 1984, 230, 94-102
17 Bassett, J. R., Cairncross, K. D., Hacket, N. B. and Story, M. Studies on the peripheral pharmacology of fenazoxine, a potential antidepressant drug. Br. J. Pharmacol. 1969, 37, 69-78
18 Cauvin, C., Loutzenhiser, R. and Van Breemen, C. Mechanism of calcium-antagonist induced vasodilation. Annu. Rev. Pharmacol. 1983, 23, 373-396
19 Pentel, P. R., WananukuI, W., Scarlett, W. and Keyler, D. E. Nitric oxide contributes to desipramine-induced hypotension in rats. Hum. Exp. Toxicol. 1996, 15, 320-328
20 Iversen, L. L. The inhibition of noradrenaline uptake by drugs. Adv. Drug Res. 1965, 2, 1-46
21 Rehavi, M., Weiss, H., Nissenkom, L, Rubinstein. R. and Cohen, S. A comparative study of the affinities of some tricyclic antidepressants for the muscarinic cholinergic receptor in human and guinea-pig bladder, ileum and brain in relation to differential drug potency. Life Sci. 1987, 40, 1819-1827
22 Pancrazio, J. J., Kamatchi. G. L., Roscoe, A. K. and Lynch, C. Inhibition of neuronal $Na^+$ channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 1998, 284, 208-214
23 Fernandez del Pozo, B., Perez-Vizcaino, F., Femandez, C., Zaragoza, F. and Tamargo, J. Effects of several class 1 antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen. Pharmacol. 1997, 29, 539-543
24 Kirch, W. Hemodynamic effects of extracardiac drugs. Int. J. Clin. Pharmacol. Ther. 1995, 33, 190-193
25 Glassman, A. H., Roose, S. P. and Bigger, J. T. Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA, 1993, 269, 2673-2675
26 Huang, Y. Inhibitory effect of noradrenaline uptake inhibitors on contractions of rat aortic smooth muscle. Br. J. Pharmacol. 1996, 117, 533-539
27 Perez-Vizcaino, E, Fernandez del Pozo, B., Zaragoza, F. and Tamargo. J. Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine. Br. J. Pharmacol. 1994, 113, 1281-1288
28 Barber, M. J., Stanner, C. F. and Grant, A. 0. Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites. Circ. Res. 1991, 69, 677-696
29 Rapoport, R. M. Effects of norepinephrine on contraction and hydrolysis of phosphatidylinositols in rat aorta. J. Pharmacol. Exp. Ther. 1987, 242, 188-194
30 Nakajima, T., Hazania, H., Hamada. E., Wu, S. N., Igarashi, K., Yainashita, T, Seyama, Y., Omata, M. and Kurachi. Y. Endothelin-l and vasopressin activate Ca(2+)-permeab1e non-selective cation channels in aortic smooth muscle cells: mechanism of receptor-mediated $Ca^2^+$ influx. J. Mol. Cell. Cardiol. 1996, 28, 707-722
31 Berridge, M. J. Rapid accumulation of inositol trisphosphate reveals that agonist.s hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem. J. 1983, 212, 849-858
32 Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P. and Weiner, C. P. Molecular mechanism of cGMP- mediated smooth muscle relaxation. J. Cell. Physiol. 2000, 184, 409-420
33 Kanno, K., Hirata, Y., Imai, T. and Marumo, F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension, 1993, 22, 34-39
34 Preskom, S. H. and Irwin, H. A. Toxicity of tricyclic antidepressants-kinetics, mechanism, intervention: a review. J. Clin. Psychiatry. 1982, 43, 151-156
35 HrdIna, P. D. and Ling, G. M. Studies on the mechanism of the inhibitory effect of desipramine (DMI) on vascular smooth muscle contraction. J. Pharmacol. Exp. Ther. 1970, 173, 407-415